Status:
COMPLETED
Evaluation of Clinical and Radiographic Outcomes of Meniscal Lesion Treatment Using Collagen Scaffolds (CMI)
Lead Sponsor:
Istituto Ortopedico Rizzoli
Conditions:
Meniscal Degeneration
Osteoarthritis of Knee
Eligibility:
All Genders
18-65 years
Brief Summary
Meniscal lesions represent the most frequently encountered joint pathology in the adult population and can cause pain symptoms, mechanical blockages, and recurrent effusions. The treatment of these le...
Eligibility Criteria
Inclusion
- Patients aged between 18 and 65 years at the time of surgery
- Both male and female patients
- Patients who underwent meniscectomy and/or CMI implantation from January 1, 1998 to December 31, 2010 at the Rizzoli Orthopedic Institute.
Exclusion
- Patients who are no longer reachable;
- Patients who do not consent to be included in the study;
- Presence of infection or hematological, rheumatic, or hemostatic disorders at the time of evaluation.
Key Trial Info
Start Date :
November 29 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 29 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06597357
Start Date
November 29 2020
End Date
November 29 2022
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Rizzoli Orthopedic Institute
Bologna, Bologna, Italy, 40136